{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2023,6,1]],"date-time":"2023-06-01T05:10:06Z","timestamp":1685596206257},"reference-count":15,"publisher":"Georg Thieme Verlag KG","issue":"04","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Thromb Haemost"],"published-print":{"date-parts":[[2014]]},"DOI":"10.1160\/th13-06-0462","type":"journal-article","created":{"date-parts":[[2013,12,12]],"date-time":"2013-12-12T10:22:32Z","timestamp":1386843752000},"page":"777-779","source":"Crossref","is-referenced-by-count":1,"title":["Characterisation of the p.A1461D mutation causing von Willebrand disease type 2B with severe thrombocytopenia, circulating giant platelets, and defective \u03b1-granule secretion"],"prefix":"10.1160","volume":"111","author":[{"given":"Tobias","family":"Obser","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Florian","family":"Oyen","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Brigitte","family":"Spath","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Katharina","family":"Holstein","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andreas","family":"Greinacher","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"James G.","family":"White","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ulrich","family":"Budde","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Carsten","family":"Bokemeyer","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Reinhard","family":"Schneppenheim","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Florian","family":"Langer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"194","published-online":{"date-parts":[[2017,11,29]]},"reference":[{"key":"ref1","doi-asserted-by":"crossref","first-page":"2103","DOI":"10.1111\/j.1538-7836.2006.02146.x","article-title":"Working Party on von Willebrand Disease Classification. Update on the pathophysiology and classification of von Willebrand disease: a report of the Subcommittee on von Willebrand Factor.","volume":"4","author":"JE Sadler","year":"2006","journal-title":"J Thromb Hae-most"},{"key":"ref2","doi-asserted-by":"crossref","first-page":"1047","DOI":"10.1056\/NEJM198005083021902","article-title":"Heightened interaction between platelets and factor VIII\/von Willebrand factor in a new subtype of von Willebrand\u2019s disease.","volume":"302","author":"ZM Ruggeri","year":"1980","journal-title":"N Engl J Med"},{"key":"ref3","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1111\/j.1538-7836.2007.02296.x","article-title":"Effect of von Willebrand disease type 2B and type 2M mutations on the susceptibility of von Willebrand factor to ADAMTS-13.","volume":"5","author":"J Rayes","year":"2007","journal-title":"J Thromb Haemost"},{"key":"ref4","doi-asserted-by":"crossref","first-page":"610","DOI":"10.3324\/haematol.2009.005751","article-title":"Clinical and laboratory versus molecular markers for a correct classification of von Willebrand disease.","volume":"94","author":"AB Federici","year":"2009","journal-title":"Haematologica"},{"key":"ref5","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1182\/blood-2008-04-152280","article-title":"Clinical and molecular predictors of thrombocy-topenia and risk of bleeding in patients with von Willebrand disease type 2B: a cohort study of 67 patients.","volume":"113","author":"AB Federici","year":"2009","journal-title":"Blood"},{"key":"ref6","doi-asserted-by":"crossref","first-page":"3348","DOI":"10.1182\/blood-2008-06-165233","article-title":"The Montreal platelet syndrome kindred has type 2B von Willebrand disease with the VWF V1316M mutation.","volume":"113","author":"SC Jackson","year":"2009","journal-title":"Blood"},{"key":"ref7","doi-asserted-by":"crossref","first-page":"903","DOI":"10.1160\/TH10-01-0079","article-title":"2B or not to be -the 45-year saga of the Montreal Platelet Syndrome.","volume":"104","author":"MC Poon","year":"2010","journal-title":"Thromb Haemost"},{"key":"ref8","doi-asserted-by":"crossref","first-page":"2062","DOI":"10.1111\/j.1538-7836.2008.03182.x","article-title":"Generation and validation of the Condensed MCMDM1VWD Bleeding Questionnaire for von Willebrand disease.","volume":"6","author":"M Bowman","year":"2008","journal-title":"J Thromb Haemost"},{"key":"ref10","doi-asserted-by":"crossref","first-page":"4894","DOI":"10.1182\/blood-2009-07-226324","article-title":"A cluster of mutations in the D3 domain of von Willebrand factor correlates with a distinct subgroup of von Willebrand disease: type 2A\/IIE.","volume":"115","author":"R Schneppenheim","year":"2010","journal-title":"Blood"},{"key":"ref11","doi-asserted-by":"crossref","first-page":"610","DOI":"10.1111\/j.1365-2516.2008.01966.x","article-title":"Contribution of genetical analysis for diagnosis of von Wille-brand\u2019s disease type 2B.","volume":"15","author":"M Victor","year":"2009","journal-title":"Haemophilia"},{"key":"ref12","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1080\/09537100500441150","article-title":"von Willebrand disease type 2B must be always considered in the differential diagnosis of genetic thrombocy-topenias with giant platelets.","volume":"17","author":"G Loffredo","year":"2006","journal-title":"Platelets"},{"issue":"S 01","key":"ref13","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1111\/j.1538-7836.2009.03371.x","article-title":"Altered mega-karyocytopoiesis in von Willebrand type 2B disease.","volume":"7","author":"AT Nurden","year":"2009","journal-title":"J Thromb Haemost"},{"key":"ref14","doi-asserted-by":"crossref","first-page":"2649","DOI":"10.1182\/blood-2009-07-231886","article-title":"Abnormal VWF modifies megakaryocytopoiesis: studies of platelets and megakaryocyte cultures from patients with von Willebrand disease type 2B.","volume":"115","author":"P Nurden","year":"2010","journal-title":"Blood"},{"key":"ref15","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1055\/s-0037-1614447","article-title":"Post-DDAVP thrombocytopenia in type 2B von Willebrand disease is not associated with platelet consumption: failure to demonstrate glycocalicin increase or platelet activation.","volume":"81","author":"A Casonato","year":"1999","journal-title":"Thromb Haemost"},{"key":"ref16","doi-asserted-by":"crossref","first-page":"704","DOI":"10.1046\/j.1365-2141.2000.02246.x","article-title":"Platelet ultra-structural abnormalities in three patients with type 2B von Willebrand disease.","volume":"110","author":"P Nurden","year":"2000","journal-title":"Br J Haematol"}],"container-title":["Thrombosis and Haemostasis"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.thieme-connect.de\/products\/ejournals\/pdf\/10.1160\/TH13-06-0462.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,31]],"date-time":"2023-05-31T12:18:46Z","timestamp":1685535526000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.thieme-connect.de\/DOI\/DOI?10.1160\/TH13-06-0462"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014]]},"references-count":15,"journal-issue":{"issue":"04","published-online":{"date-parts":[[2017,11,20]]},"published-print":{"date-parts":[[2014]]}},"URL":"https:\/\/doi.org\/10.1160\/th13-06-0462","archive":["Portico","CLOCKSS"],"relation":{},"ISSN":["0340-6245","2567-689X"],"issn-type":[{"value":"0340-6245","type":"print"},{"value":"2567-689X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014]]}}}